Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Pedram Gerami"'
Autor:
Jonathan S. Zager, Brian R. Gastman, Sancy Leachman, Rene C. Gonzalez, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah I. Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The heterogeneous behavior of patients with melanoma makes prognostication challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk was previously developed. This study evaluates the GEP’s pr
Externí odkaz:
https://doaj.org/article/51ad8d737b2d423ab145b5125b6bb24a
Publikováno v:
Pathology. 55:196-205
Autor:
Cecilia Lezcano, Marianne Berwick, Li Luo, Raymond Barnhill, Lyn M. Duncan, Pedram Gerami, Lori Lowe, Jane L. Messina, Richard A. Scolyer, Benjamin Wood, Iwei Yeh, Artur Zembowicz, Klaus J. Busam
Publikováno v:
Pathology. 55:223-226
Autor:
Anastasiya Boutko, Sepideh Asadbeigi, Andrew Roth, Nathaniel Lampley, Shantel Olivares, David Dittmann, Lawrence Jennings, Pedram Gerami
Publikováno v:
The American Journal of Dermatopathology. 45:289-299
Autor:
Andrew, Roth, Anastasiya, Boutko, Nathaniel, Lampley, Soneet, Dhillon, Michael, Hagstrom, Shantel, Olivares, David, Dittman, Lawrence, Jennings, Lucas, Santana Dos Santos, Klaus, Busam, Pedram, Gerami
Publikováno v:
American Journal of Surgical Pathology. 47:318-325
Desmoplastic melanomas (DMs) are often challenging to diagnose and ancillary tests, such as immunohistochemistry, have limitations. One challenge is distinguishing DM from benign desmoplastic melanocytic neoplasms. In this study, we explored the util
Autor:
Blake E. Vest, Christina L. Harview, Vincent Liu, Brian L. Swick, Kristen G. Berrebi, Shantel Olivares, Mary S. Stone, Michael R. Sargen, Pedram Gerami
Publikováno v:
Journal of Cutaneous Pathology. 49:1025-1030
Autor:
Soneet Dhillon, Daniela Duarte-Bateman, Graham Fowler, Michael Norman Eun Hagstrom, Nathaniel Lampley, Shantel Olivares, Mónica Stella Fumero-Velázquez, Kathryn Vu, Jeffrey D. Wayne, Brian R. Gastman, John Vetto, Pedram Gerami
Publikováno v:
Archives of Dermatological Research.
Autor:
Mario E. Lacouture, Dennis P. West, Alfred Rademaker, Ximing J. Yang, Nicholas Talarico, Pedram Gerami, Joan Guitart, Marissa Newman, Kimberly Nicholson, Beatrice Nardone
Purpose: Human epidermal growth factor receptor (HER) 1 and HER 1/2 inhibitors have shown benefit against a wide range of solid tumors. However, their use is associated with rash in 40% to 90% of patients, which impacts quality of life and interrupts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4464ab314e6000299c4bc3915d172ff
https://doi.org/10.1158/1078-0432.c.6518487
https://doi.org/10.1158/1078-0432.c.6518487
Autor:
Mario E. Lacouture, Dennis P. West, Alfred Rademaker, Ximing J. Yang, Nicholas Talarico, Pedram Gerami, Joan Guitart, Marissa Newman, Kimberly Nicholson, Beatrice Nardone
Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0550fa60ba16f57acc49da8aa9663e06
https://doi.org/10.1158/1078-0432.22441410
https://doi.org/10.1158/1078-0432.22441410
Autor:
Soneet Dhillon, Daniela Duarte-Bateman, Graham Fowler, Michael Norman Eun Hagstrom, Nathaniel Lampley, Shantel Olivares, Mónica Stella Fumero-Velázquez, Kathryn Vu, Jeffrey D. Wayne, Brian R. Gastman, John Vetto, Pedram Gerami
Publikováno v:
Archives of Dermatological Research.